Troy Burke appointed Managing Director of Boston Scientific Australia & New Zealand

Introducing Our New Managing Director: Troy Burke
We are excited to announce a significant leadership change at Boston Scientific Australia & New Zealand. After an incredibly fulfilling tenure leading the Boston Scientific ANZ organisation, Michael Baulch has been appointed Vice President, Global Cardiac Rhythm Management, and will be relocating to the US. We are thrilled to share that Troy Burke has been appointed as the new Vice President and Managing Director of Boston Scientific Australia & New Zealand.
About Troy Burke
Troy Burke has been with Boston Scientific for over 25 years, working across multiple therapy areas including Cardiac Rhythm Management, Electrophysiology, Interventional Cardiology, Structural Heart, and Peripheral Interventions. He has extensive experience in the ANZ market and has spent time living in China and working across wider Asia Pacific with his most recent role overseeing our regional Atrial Fibrillation business.
All images are the property of Boston Scientific. All trademarks are the property of their respective owners.
Individual symptoms, situations, circumstances and results may vary. This website is meant for information purposes only, it is not intended to be used for medical diagnosis or treatment or as a substitute for professional medical advice. Please consult your doctor or qualified healthcare provider regarding your condition and appropriate medical treatment. This site is intended for Australian and New Zealand residents only. Please review the Boston Scientific Privacy Policy for practices on the collection, storage, use and disclosure of your personal information.
CAUTION: Indications, contraindications, warnings, and instructions for use can be found in the product labelling supplied with each device or at www.IFU-BSCI.com.